AFDX-384
| Identifikatori | |
|---|---|
| CAS broj | 118290-27-0 |
| PubChem | CID 119357 |
| ChemSpider | 26233613 |
AFDX-384 (BIBN-161) je lek koji deluje kao selektivni muskarinski acetilholinski antagonist, sa selektivnošću za M2 i M4 podtipove. On se uglavnom koristi za mapiranje distribucije M2 i M4 muskarinskih receptora u mozgu, i studiranje njihovog učešća u razvoju i tretmanu demencije i šizofrenije.[1][2][3][4][5][6][7]
Reference
- ^ Tränkle C, Andresen I, Lambrecht G, Mohr K (1998). „M2 receptor binding of the selective antagonist AF-DX 384: possible involvement of the common allosteric site”. Molecular Pharmacology. 53 (2): 304—12. PMID 9463489.
- ^ Kitaichi K, Day JC, Quirion R (1999). „A novel muscarinic M(4) receptor antagonist provides further evidence of an autoreceptor role for the muscarinic M(2) receptor sub-type”. European Journal of Pharmacology. 383 (1): 53—6. PMID 10556681. doi:10.1016/S0014-2999(99)00607-X.
- ^ Martin J, Deagostino A, Perrio C, Dauphin F, Ducandas C, Morin C, Desbène PL, Lasne MC (2000). „Syntheses of R and S isomers of AF-DX 384, a selective antagonist of muscarinic M2 receptors”. Bioorganic & Medicinal Chemistry. 8 (3): 591—600. PMID 10732976. doi:10.1016/S0968-0896(99)00307-7.
- ^ Piggott M, Owens J, O'Brien J, Paling S, Wyper D, Fenwick J, Johnson M, Perry R, Perry E (2002). „Comparative distribution of binding of the muscarinic receptor ligands pirenzepine, AF-DX 384, (R,R)-I-QNB and (R,S)-I-QNB to human brain”. Journal of Chemical Neuroanatomy. 24 (3): 211—23. PMID 12297267. doi:10.1016/S0891-0618(02)00066-2.
- ^ Zavitsanou K, Katsifis A, Yu Y, Huang XF (2005). „M2/M4 muscarinic receptor binding in the anterior cingulate cortex in schizophrenia and mood disorders”. Brain Research Bulletin. 65 (5): 397—403. PMID 15833594. doi:10.1016/j.brainresbull.2005.02.007.
- ^ Teaktong T, Piggott MA, Mckeith IG, Perry RH, Ballard CG, Perry EK (2005). „Muscarinic M2 and M4 receptors in anterior cingulate cortex: relation to neuropsychiatric symptoms in dementia with Lewy bodies”. Behavioural Brain Research. 161 (2): 299—305. PMID 15922057. doi:10.1016/j.bbr.2005.02.019.
- ^ Gibbons AS, Scarr E, McLean C, Sundram S, Dean B (2009). „Decreased muscarinic receptor binding in the frontal cortex of bipolar disorder and major depressive disorder subjects”. Journal of Affective Disorders. 116 (3): 184—91. PMC 2724602
. PMID 19103464. doi:10.1016/j.jad.2008.11.015.
Vidi još
- Pirenzepin (M1 selektivni antagonist)
| Molimo Vas, obratite pažnju na važno upozorenje u vezi sa temama iz oblasti medicine (zdravlja). |
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.